| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/22/1996 | WO1996005228A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
| 02/22/1996 | WO1996005226A1 POLYNUCLEOTIDE ENCODING C5a RECEPTOR |
| 02/22/1996 | WO1996005225A1 Adrenergic receptor |
| 02/22/1996 | WO1996005222A1 Purification and pharmaceutical compositions containing type g botulinum neurotoxin |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004926A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ η1 CHAIN |
| 02/22/1996 | WO1996004925A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 02/22/1996 | WO1996004788A1 Antisense and triplex therapeutic agents and methods |
| 02/22/1996 | CA2197712A1 Vaccines containing borrelia burgdorferi ospg |
| 02/22/1996 | CA2197497A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | CA2197446A1 Antigenically-marked non-infectious retrovirus-like particles |
| 02/22/1996 | CA2197232A1 Method of producing single-chain fv molecules |
| 02/22/1996 | CA2197117A1 Antisense and triplex therapeutic agents and methods |
| 02/22/1996 | CA2196080A1 Protein toxins active against lepidopteran pests |
| 02/22/1996 | CA2196053A1 Two non-contiguous regions contribute to nidogen binding to a single egf-like motif of the laminin .gamma.1 chain |
| 02/21/1996 | EP0540573B1 Assay of free and complexed prostate-specific antigen (psa) |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/20/1996 | US5493008 Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain |
| 02/20/1996 | US5492890 Polypeptides for promoting cell attachment |
| 02/20/1996 | US5492817 Coupled transcription and translation in eukaryotic cell-free extract |
| 02/20/1996 | US5492694 Fusobacterium leukotoxoid vaccine |
| 02/20/1996 | CA2018211C Modified hvi-type hirudin and process for the manufacture thereof |
| 02/20/1996 | CA1338079C Adhesion protein micelles |
| 02/20/1996 | CA1338077C Heterodimeric transforming growth factor-beta |
| 02/17/1996 | CA2156132A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 02/15/1996 | WO1996004557A2 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 02/15/1996 | WO1996004391A1 Method for selecting high-expressing host cells |
| 02/15/1996 | WO1996004388A1 Novel compounds |
| 02/15/1996 | WO1996004387A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 02/15/1996 | WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/15/1996 | WO1996004378A2 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | WO1996004377A1 Production of tissue factor pathway inhibitor |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996004313A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 02/15/1996 | WO1996004310A1 Contraceptive vaccine |
| 02/15/1996 | WO1996004309A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 02/15/1996 | WO1996004307A1 Aspb1 insulin analogs |
| 02/15/1996 | WO1996002645A3 Htk ligand |
| 02/15/1996 | WO1995032285A3 Transgenic arthritic mice |
| 02/15/1996 | WO1995021250A3 Production of pharmaceutical-grade plasmid dna |
| 02/15/1996 | DE3891231C2 Astigmatism correcting laser surgical set |
| 02/15/1996 | CA2196679A1 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 02/15/1996 | CA2196569A1 Aspb1 insulin analogs |
| 02/15/1996 | CA2196290A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | CA2196285A1 Contraceptive vaccine |
| 02/15/1996 | CA2196200A1 Novel compounds |
| 02/15/1996 | CA2195672A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 02/15/1996 | CA2195312A1 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| 02/15/1996 | CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/14/1996 | EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus |
| 02/14/1996 | EP0696597A2 Monoclonal antibodies for selective immunological determination of high molecular weight intact laminin forms in body fluids |
| 02/14/1996 | EP0696325A1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c |
| 02/14/1996 | EP0696323A1 Recombinant alanine racemase and gapdh from tolypocladium |
| 02/14/1996 | EP0696322A1 METHODS AND COMPOSITIONS FOR $i(SALMONELLA)-BASED VACCINES |
| 02/14/1996 | EP0696321A1 Macrophage inflammatory protein variants |
| 02/14/1996 | EP0696320A1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 02/14/1996 | EP0696317A1 HUMAN $i(SYK) |
| 02/14/1996 | EP0389538B1 yETHOD OF PURIFYING RECOMBINANT t-PA FROM CORRESPONDING HOST CELL PROTEINS |
| 02/14/1996 | EP0205579B1 Methods and compositions useful in the diagnosis and treatment of autoimmune diseases |
| 02/14/1996 | CN1030999C Process for preparation of trypsin inhibitor |
| 02/13/1996 | US5491216 Tri-arginine insulins |
| 02/13/1996 | US5491088 Genetic engineering |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/13/1996 | US5491066 Specifically reacts with active human ceruloplasmin; diagnosis of wilson's disease |
| 02/13/1996 | US5491065 Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF |
| 02/08/1996 | WO1996003651A1 Peptides marked with metal chelates |
| 02/08/1996 | WO1996003522A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003521A1 Vectors and transformed host cells for recombinant protein production at reduced temperatures |
| 02/08/1996 | WO1996003519A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003514A1 Picornavirus l proteinase and methods of making and using thereof |
| 02/08/1996 | WO1996003512A1 Calcium independent cytosolic phospholipase a2/b enzymes |
| 02/08/1996 | WO1996003504A1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 02/08/1996 | WO1996003501A1 Dual hybrid system |
| 02/08/1996 | WO1996003438A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | WO1996003433A1 New process for the production of biologically active protein |
| 02/08/1996 | WO1996003430A1 Organic compounds |
| 02/08/1996 | WO1996003428A1 Antiprotozoal cyclic tetrapeptides |
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003146A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/08/1996 | WO1996003048A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 02/08/1996 | WO1996003043A1 Human brain specific kinase |
| 02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
| 02/08/1996 | DE4426632A1 Labelling immunoglobulin mols., esp. monoclonal antibodies |
| 02/08/1996 | DE4418936A1 Polypeptid Polypeptide |
| 02/08/1996 | CA2195969A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 02/08/1996 | CA2195868A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | CA2195669A1 Picornavirus l proteinase and methods of making and using thereof |
| 02/08/1996 | CA2195648A1 Metal chelate-labelled peptides |
| 02/08/1996 | CA2194999A1 Antiprotozoal cyclic tetrapeptides |
| 02/08/1996 | CA2194973A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/08/1996 | CA2194578A1 New process for the production of biologically active protein |
| 02/07/1996 | EP0695803A2 Epitopic regions of pneumococcal surface protein A |
| 02/07/1996 | EP0695801A2 Yeast protein derived peptide compositions, a process for preparing them and their use |
| 02/07/1996 | EP0695368A1 Random chemistry for the generation of new compounds |
| 02/07/1996 | EP0695361A1 Expression of heterologous genes according to a targeted expression profile |
| 02/07/1996 | EP0695357A1 Mammal cell lines and method of obtaining glycoproteins |
| 02/07/1996 | EP0695355A1 Protein having tpo activity |
| 02/07/1996 | EP0695311A1 Cellulose binding domain |
| 02/07/1996 | EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |